yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q33403609-FB667613-257D-48BF-AFAC-5C0F400A3154
Q33403609-FB667613-257D-48BF-AFAC-5C0F400A3154
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33403609-FB667613-257D-48BF-AFAC-5C0F400A3154
Expected benefits of topotecan combined with lapatinib in recurrent ovarian cancer according to biological profile: a phase 2 trial.
P1476
Q33403609-FB667613-257D-48BF-AFAC-5C0F400A3154
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33403609-FB667613-257D-48BF-AFAC-5C0F400A3154
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
685b50ead4ef606f5943ca1d828fca5486658f30
P1476
Expected benefits of topotecan
......
ical profile: a phase 2 trial.
@en